A second financing round was closed with NBank Capital, the investment company of NBank. Additional investors came from the private sector in Braunschweig. CORAT Therapeutics is in close coordination with the regulatory authorities and expects the green light for the start of clinical testing shortly.
“The development of a drug against Corona must not fail because of money. We need drugs against Corona just as urgently as vaccines. The Braunschweig biotech company CORAT Therapeutics GmbH is close to the goal of testing a drug on patients that has been highly effective in all experiments to date. That is why we as a state are providing further risk capital so that valuable time is not lost. We will continue to provide intensive support for this Lower Saxony success story.”Dr. Bernd Althusmann, Minister of Economics